Skip to main content
   DALAL STREET TOWER TALK

VRL Logistics (Rs. 366.00) (Code: 539118)

The company has registered 40% rise in net profit for June quarter, which has added pace to the stock. However, the failure of the government to pass the GST bill in the parliament has been a dampener, and led to a sharp correction in the share. The company has strong fundamentals and can give good returns in the coming days.

Educomp Solutions (Rs. 13.00) (Code: 532696)

This education sector company is setting up new branches in the country. Considering the government's focus on education sector, the stock could be in for some good times going ahead

Nectar LifeScience (Rs 39)

Singapore Based Operators Are Bullish Watch out for 50 levels next.. decent set of numbers.. with new plant coming up and brazil acquisition showing progress in the near future.. Nectar can very much move towards 3 digit Mark.

Pratibha Industries (49)

The result has given enough steam to take the scrip to 70/-. I wouldn`t be surprised to see a tripple digit entry in New Year. Invest deeply and confidently. Cheers !!!!

Makers Laboratories (Rs. 88.00) (Code: 506919)


Makers Lab is a producer of branded generics and a fast-growing pharma company. Its shares are listed in B group and have face-value of Rs. 10. Its top formulation brands include Duramol (paracetamol), Artemak AB (BArtheeter), Loroquin (chloroclin), Nimuwin, Coffwin (anti coughrage), and Exylin (Amoxycillin range). The company has strong pan-India presence. In the first quarter of 2016, it has registered 135% rise in net profit at Rs. 1.32 crores, while sales rose 3% to Rs. 17.41 crores. Company's equity is Rs. 4.92 crores, net-worth Rs. 25 crores, and has market cap of Rs. 44 crores. The stock is trading at a PE multiple of only 14, which is lower than its peers. The stock can be seen at Rs. 140 levels in next 2 - 3 monts.

Comments

Post a Comment

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...
1 comment
Read more

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...
1 comment
Read more

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...
Post a Comment
Read more